Literature DB >> 16715395

Biantennary glycans as well as genetic variants of alpha1-acid glycoprotein control the enantioselectivity and binding affinity of oxybutynin.

Tomoko Kimura1, Akimasa Shibukawa, Katsumi Matsuzaki.   

Abstract

PURPOSE: The purpose of this study was to investigate the role of biantennary branching glycans of alpha1-acid glycoprotein (AGP) and its genetic variants in the enantioselective binding of oxybutynin (OXY).
METHOD: Human native AGP was separated using imminodiacetate-copper (II) affinity chromatography into two fractions, the A variant and a mixture of the F1 and S variants (F1-S). These fractionated AGPs were further separated by concanavalin A affinity chromatography into two fractions, with and without biantenarry glycans. An on-line high-performance liquid chromatography (HPLC) system consisting of a high-performance frontal analysis column, an extraction column, and an analytical HPLC column was developed to determine the binding affinities of OXY enantiomers for respective AGP species.
RESULTS: The total binding affinity as well as the enantiomeric selectivity of OXY in the F1-S mixed variant was significantly higher than that for the A variant, indicating that the chiral recognition ability of native AGP for the OXY enantiomers highly depends on the F1-S mixed variant. Furthermore, not only the genetic variants but also bianntenary glycans of AGP affect the binding affinity of OXY and are also responsible for the enantioselectivity.
CONCLUSIONS: Both genetic variants and glycan structures significantly contribute to the enantioselectivity and the binding affinity of OXY.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16715395     DOI: 10.1007/s11095-006-9777-8

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  37 in total

1.  Inflammation-induced changes in expression and glycosylation of genetic variants of alpha 1-acid glycoprotein. Studies with human sera, primary cultures of human hepatocytes and transgenic mice.

Authors:  W van Dijk; O Pos; M E van der Stelt; H J Moshage; S H Yap; L Dente; P Baumann; C B Eap
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

Review 2.  High-performance frontal analysis for drug-protein binding study.

Authors:  A Shibukawa; Y Kuroda; T Nakagawa
Journal:  J Pharm Biomed Anal       Date:  1999-01       Impact factor: 3.935

Review 3.  Drug binding to human alpha-1-acid glycoprotein in health and disease.

Authors:  J M Kremer; J Wilting; L H Janssen
Journal:  Pharmacol Rev       Date:  1988-03       Impact factor: 25.468

4.  Stereoselective determination of free warfarin concentration in protein binding equilibrium using direct sample injection and an on-line liquid chromatographic system.

Authors:  A Shibukawa; M Nagao; Y Kuroda; T Nakagawa
Journal:  Anal Chem       Date:  1990-04-01       Impact factor: 6.986

5.  Isoelectric focusing of alpha-1 acid glycoprotein (orosomucoid) in immobilized pH-gradients with 8M urea: detection of its desialylated variants using an alkaline phosphatase-linked secondary antibody system.

Authors:  C B Eap; P Baumann
Journal:  Electrophoresis       Date:  1988-10       Impact factor: 3.535

Review 6.  Alpha 1-acid glycoprotein (orosomucoid): pathophysiological changes in glycosylation in relation to its function.

Authors:  W van Dijk; E C Havenaar; E C Brinkman-van der Linden
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

7.  Orosomucoid (ORM) typing by isoelectric focusing: evidence for gene duplication of ORM1 and genetic polymorphism of ORM2.

Authors:  I Yuasa; K Suenaga; K Umetsu; K Ito; M Robinet-Levy
Journal:  Hum Genet       Date:  1987-11       Impact factor: 4.132

8.  Alpha 1-acid glycoprotein concentration and molecular heterogeneity: relationship to oxprenolol binding in serum from healthy volunteers and patients with lung carcinoma or cirrhosis.

Authors:  N F Fraeyman; C D Dello; F M Belpaire
Journal:  Br J Clin Pharmacol       Date:  1988-06       Impact factor: 4.335

9.  Evidence for alpha-1-acid glycoprotein populations of different pI values after concanavalin A affinity chromatography. Study of their evolution during inflammation in man.

Authors:  I Nicollet; J P Lebreton; M Fontaine; M Hiron
Journal:  Biochim Biophys Acta       Date:  1981-04-28

10.  Glycosylation study of the major genetic variants of human alpha1-acid glycoprotein and of their pharmacokinetics in the rat.

Authors:  Françoise Hervé; Philippe d'Athis; Dominique Tremblay; Jean-Paul Tillement; Jérôme Barré
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2003-12-25       Impact factor: 3.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.